Moderna | GJELD



Debt Endring Dato
Acadia Pharmaceuticals USD 0 0 2024-12
Adcock Ingram Holdings ZAR 280.54M 199.53M 2024-06
Agios Pharmaceuticals USD 0 0 2024-12
Alnylam Pharmaceuticals USD 1.02B 967K 2024-12
Amgen USD 60.1B 299M 2024-12
Arrowhead Research USD 409.41M 16.23M 2024-12
Biogen USD 6.3B 1.9M 2024-12
BioMarin Pharmaceutical USD 596.24M 1.61M 2024-12
Celltrion KRW 2.19T 18.16B 2024-09
Cspc Pharmaceutical CNY 388.87M 318.03M 2024-06
Dianthus Therapeutics USD 0 0 2024-09
Gilead Sciences USD 26.71B 3.46B 2024-12
GlaxoSmithKline GBP 16.99B 927M 2024-12
Incyte USD 37.96M 5.81M 2024-12
Ionis Pharmaceuticals USD 1.25B 32.8M 2024-12
Kangmei Pharma CNY 253.72M 1.04B 2024-09
Knight Therapeutics CAD 58.22M 109K 2024-09
Laboratorios Farma EUR 121.16M 39.38M 2024-06
Malin Corporation EUR 0 100K 2024-06
Moderna USD 62M 593M 2024-12
Organigram Holdings CAD 44.74M 12.56M 2024-12
Pharma Mar EUR 51.08M 1.99M 2024-12
Qiagen NV USD 1.39B 528.29M 2024-12
Regeneron Pharmaceuticals USD 2.7B 400K 2024-12
Sarepta Therapeutics USD 1.14B 90.44M 2024-12
Sartorius EUR 4.53B 98.7M 2024-09
Sino Biopharmaceutical CNY 9.68B 2.9B 2024-06
Tilray USD 351.72M 15.26M 2024-11
Ultragenyx Pharmaceutical USD 0 0 2024-12
United Therapeutics USD 300M 100M 2024-12
Vertex Pharmaceuticals USD 112.8M 1.2M 2024-12
Zz Pientze Pharmaceu 1.18B 115.85M 2024-09



Moderna GJELD - Gjeldende verdier, historiske data, prognoser, statistikk, diagrammer og økonomiske kalender - Mar 2025.